Research Project in association with Protocol WN25203 "CSF sample retention for biomarker assay development" [SUBSTUDY OF 700060548]

Trial Profile

Research Project in association with Protocol WN25203 "CSF sample retention for biomarker assay development" [SUBSTUDY OF 700060548]

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 16 Jun 2016

At a glance

  • Drugs Gantenerumab (Primary)
  • Indications Alzheimer's disease
  • Focus Biomarker; Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 06 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top